Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II / III clinical trial of NFL-101 for smoking cessation

Next Previous
Trial Profile

Phase II / III clinical trial of NFL-101 for smoking cessation

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 27 Apr 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs NFL 101 (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use

Most Recent Events

  • 25 Apr 2023 According to a NFL Biosciences media release, company has submitted a request for scientific advice to the EMA with a view to determining the future development of NFL-101 before its marketing authorization. This scientific advice will be issued in the second quarter of 2023.
  • 25 Apr 2023 According to a NFL Biosciences media release, funds raised on Jan 31, 2023 has been allocated to finalizing this Phase II/III clinical trial. Together, these resources will make it possible to finalize the CESTO II study.
  • 25 Apr 2023 According to a NFL Biosciences media release, patient recruitment started in Jan 2022, gradually mobilizing a total of eight Clinical Investigation Centers. The final recruitments were completed by the end of April 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top